Contemporary Intravesical Treatment Options for Urothelial Carcinoma of the Bladder

By Brassell Stephen A.   Kamat Ashish M.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 10, 2006-11 ,pp. : 1027-1036

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Elevated Lysosome-associated Protein Transmembrane-4β-35 is an Independent Prognostic Marker in Pancreatic Carcinoma

By Zhang G   Liang Y   Huang Y   Chen Y   Zhou R  

The Journal of International Medical Research, Vol. 40, Iss. 4, 2012-07 ,pp. : 1275-1283

Field House Publishing

Access to resources Recommend Favorite

Novel molecular targets for the therapy of urothelial carcinoma

By Jana Bagi RP   Galsky Matthew D   Hahn Noah M   Milowsky Matthew I   Sonpavde Guru  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 5, 2012-05 ,pp. : 499-513

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma

By Li Shuang-Xi   Tang Gu-Sheng   Zhou Dong-Xun   Pan Yu-Fei   Tan Ye-Xiong   Zhang Jian   Zhang Bo   Ding Zhi-Wen   Liu Li-Juan   Jiang Tian-Yi   Hu He-Ping   Dong Li-Wei   Wang Hong-Yang  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1520-1531

Blackwell Publishing

Access to resources Recommend Favorite

Cathepsin L is Associated with Proliferation and Clinical Outcome of Urothelial Carcinoma of the Bladder

By Yan J-A   Xiao H   Ji H-X   Shen W-H   Zhou Z-S   Song B   Chen Z-W   Li W-B  

The Journal of International Medical Research, Vol. 38, Iss. 6, 2010-11 ,pp. : 1913-1922

Field House Publishing

Access to resources Recommend Favorite